Objective To study the changes of the spleen and splenic venous hemodynamics in liver cirrhosis patients with portal hypertension and ITP before and after therapeutic splenic artery embolization.
目的观察肝硬化门静脉高压患者和特发性血小板减少性紫癜(itp)患者行脾动脉栓塞术前后脾脏及脾静脉血流动力学变化。
Silent cirrhosis may be discovered after the finding of asymptomatic thrombocytopenia caused by the congestive splenomegaly of portal hypertension .
静息性的肝硬化可能在出现因门脉高压引起的充血性脾肿大导致的无症状的血小板减少症之后才被发现。
Objective: To study the changes of the spleen and splenic venous hemodynamics in liver cirrhosis patients with portal hypertension before and after therapeutic splenic artery embolization.
目的：观察肝硬化门静脉高压症患者行脾动脉栓塞术前后脾脏及脾静脉血流动力学变化。
Objective To research the anticoagulants in protecting the portal vein obstruction after splenectomy due to the portal hypertension of hepatic cirrhosis.
目的：探讨肝硬化、门脉高压症行脾切除术后早期应用抗凝药物对预防门静脉血栓的意义。
Objective: to evaluate the clinical value of spiral ct during arterial portography (SCTAP) in judgment of cirrhosis and portal hypertension.
目的：评价螺旋CT经动脉门静脉造影(SCTAP)对肝硬化、门静脉高压判断的临床价值。
Objective to analyze the relevant factors and explore methods for prevention of portal vein thrombosis in patients after splenectomy for portal hypertension due to cirrhosis resulting from hepatitis.
目的分析肝炎肝硬化门静脉高压症脾切除术后门静脉系统形成血栓的相关因素，寻找预防门静脉高压症脾切除术后门静脉系统形成血栓的方法。
Conclusion: MRI special sequences and methods play a significant role in the early diagnosis of liver cirrhosis and portal hypertension.
结论：利用MRI的特殊序列和检查方法在肝硬化和门脉高压早期诊断中有重要价值。
One of the most common causes for splenomegaly is portal hypertension with cirrhosis of the liver.
脾肿大常见原因之一是肝硬化门静脉高压。
Objective To explore the effects of portal nutrition on liver cirrhosis and portal hypertension.
目的探讨门静脉营养在治疗肝硬化、门脉高压症中的作用。
Purpose To observe the relationship between portal pressure and the expression of HO-CO system in liver of patients with hepatic cirrhosis and the effect on portal hypertension in hepatic cirrhosis.
目的观察HO CO系统在肝硬化病人肝组织中的表达及与门静脉压力的关系，以探讨其在肝硬化门脉高压中的作用。
Objective: To evaluate the diagnostic value of the special sequences and methods of MRI in liver cirrhosis and portal hypertension.
目的：通过核磁共振成像（MRI）的特殊序列和检查方法，评价MRI在肝硬化和门脉高压早期诊断中的作用。
Objective To study the diagnosis and treatment of portal hypertension in secondary biliary cirrhosis(PHSBC).
目的探讨继发性胆汁性肝硬变门脉高压症的诊断和治疗。
Objective: to investigate the hypercoagulation of the rats with cirrhosis and portal hypertension after splenectomy.
目的：探讨肝硬化门静脉高压症大鼠脾切除术后高凝状态的原因。
Objective: to investigate the surgical treatment of 15 patients with portal hypertension of secondary biliary cirrhosis due to hepatolithiasis (PHSBCH).
目的：探讨15例因肝胆管结石至胆管狭窄合并胆汁性肝硬变门脉高压症(PHSBCH)的外科治疗。
Objective To sum up the experience in the peri-operative management of gastrointestinal tumor with liver cirrhosis and portal hypertension.
目的总结肝硬化门静脉高压症合并胃肠肿瘤患者围手术期处理经验。
This magnetic resonance imaging (MRI) scan of the abdomen in transverse view demonstrates a small, nodular liver with cirrhosis. The spleen is enlarged from portal hypertension.
腹部横断面mri影像显示体积小而有结节的硬化性肝脏。可见由门静脉高压导致的体积增大的脾脏。
Objective To evaluate the diagnostic value in liver cirrhosis with portal hypertension between ultrasound and computer tomography (CT).
目的超声与CT对照在肝硬化门静脉高压症中的诊断应用。
AIM: to study the curative effect and clinical significance of the partial spleen artery embolization (PSE) in the treatment of hepatic cirrhosis together with portal hypertension and hypersplenism.
目的：探讨部分脾动脉栓塞术(PSE)治疗肝炎肝硬化门静脉高压症并发脾功能亢进的疗效及临床意义。
Objective: to analyze electron beam ct angiography characteristics of portal hypertension in liver cirrhosis and to investigate its value of clinical application.
目的：分析肝硬化门脉高压电子束ct血管造影表现，探讨其临床应用价值。
International Digest: Portal hypertension and its complications such as variceal hemorrhage, ascites, and encephalopathy are common in cirrhosis.
《国际肝病》：门脉高压及其并发症如静脉曲张出血，腹水和肝性脑病在肝硬化患者较常见。
The diagnosis of hepatic hydrothorax should be suspected in a patient with established cirrhosis and portal hypertension, presenting with a unilateral pleural effusion, most commonly right-sided.
病人患有肝硬化和门脉高压症，很可能会发生肝性胸水，最常见的是右侧单侧胸腔积液。
Such four cases as ascites due to cirrhosis, portal hypertension; non-alcoholic fatty liver and jaundice were presented for a detailed explanation.
今举肝硬化腹水、门静脉高压症、非酒精性脂肪肝、黄疸四则验案详细说明之。
Conclusion Partial splenic embolization can reduce pressure of portal hypertension and is a effective therapy of hypersplenism in cirrhosis.
结论部分性脾栓塞术后可明显降低门脉压力及改善脾功能亢进。
Conclusion: The combination of EVL and PSE is safe and simple. Its recent curative effect on portal hypertension due to cirrhosis is definite.
结论：EVL联合PSE方法简单、安全，对肝硬化所致的门脉高压症近期疗效确切。
Portal hypertension occurs as a consequence of structural changes within the liver in cirrhosis and increased splanchnic blood flow.
门脉高压是硬化肝内结构性变化及内脏血流增加的结果。
The therapeutic management of hepatic portal hypertension in patients with cirrhosis is still a challenge.
肝硬化门静脉高压症的治疗对腹部外科学仍是一个挑战。
Liver cirrhosis; Helicobacter pylori; Pepetic ulcer; Portal hypertension; Endotoxemia.
肝硬化；幽门螺杆菌；消化性溃疡；门脉高压；内毒素血症。
Methods PTO is applied to treat 13 portal hypertension patients with cirrhosis, then PSE is applied.
方法对13例肝硬化门脉高压患者行pto治疗，然后进行PSE。
The advanced patients often possess severe jaundice, severe liver dysfunction, biliary cirrhosis, portal hypertension.
晚期病人常有重度黄疸、严重肝功效损害、胆汁性肝硬变、门静脉高压症的表现。
Abdominal ultrasound examinations showed cirrhosis, portal hypertension, splenomegaly. Echocardiogram showed left ventricular myohypertrophia, mild mitral and tricuspid valve insufficiency.
腹部超声示肝硬化、门脉高压和巨脾，超声心动图示心肌肥大、二尖瓣和三尖瓣轻度关闭不全；
应用推荐